UroCor, Inc.


Feb 22, 00

22:38 ET UroCor Announces Fourth Quarter and Year-End 1999 Results

 
Feb 17, 00

22:41 ET UroCor Begins Shipment of ProstaSeed(TM) I-125 Sources For Radiation Treatment Of Prostate Cancer

 
Jan 11, 00

22:43 ET UroCor Launches ProstaSeed(TM) I-125 Sources for Use as Implants in Prostate Cancer Therapy

 
Jan 06, 00

22:49 ET UroCor Hires John L. Armstrong, Jr. to Lead Company's Move into Therapeutics

 
Nov 22, 99

22:58 ET Johns Hopkins and Urocor Develop Method for Improved Prediction of Prostate Cancer Recurrence Following Surgery

 
Nov 01, 99

23:03 ET UroCor and Prostate Services of America Sign Cancer Therapy Marketing Agreement

 
Oct 26, 99

23:07 ET Urocor Announces Third Quarter 1999 Results

 
Oct 25, 99

23:12 ET UroCor Chairman & C.E.O. William A. Hagstrom Stepping Down to Focus on Other Ventures

 
Oct 21, 99

23:20 ET UroCor Forges Alliance With Healtheon to Expand Its Internet Transaction Capabilities

 
Sep 09, 99

23:26 ET UroCor, Mallinckrodt Sign Agreement to Sell Prostate Cancer Radiotherapy

 
Mar 09, 98

11:06 ET Prostate Cancer Trends in American Men Reported in UroCor's Study Of Two Years of Client Prostate Biopsies

 
Feb 24, 98

16:17 ET UroCor Announces Fourth Quarter, Year-End 1997 Results

 
Jan 09, 98

17:16 ET UroCor Completes National Sales Force Expansion & Training for Zeneca Co-Promotion

 
Dec 23, 97

16:15 ET UroCor Announces Addition of Two Directors: Aaron Beam, Jr. and Thomas C. Ramey

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2005 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.